Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
- November -
December
|
2002
-
2003
-
2004
-
2005
-
2006
- 2007 -
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
-
2026
November 2007 - 34 products
L
IP
CI
Wellbutrin XR 150 mg
30 Tablette(n)
14.05
31.60
10 %
Retard-Tabletten: Bupropioni Hydrochloridum 150 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
L
IP
CI
Wellbutrin XR 300 mg
30 Tablette(n)
23.10
41.40
10 %
Retard-Tabletten: Bupropioni Hydrochloridum 300 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
SIP
IP
Ferinject 100 mg / 2 ml
5 1 Ampulle(n) à 2 ml
106.49
127.65
20 %
Dispersion zur Injektion/Infusion: Ferrum 100mg / 2ml
Vifor (International)
Inc.
B / SL / SO
FB
G
SIP
IP
Ferinject 500 mg / 10 ml
Ampulle(n) à 10 ml
106.49
127.65
20 %
Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml
Vifor (International)
Inc.
B / SL / SO
FB
G
SIP
IP
Ferinject 1000 mg / 20 ml
Ampulle(n) à 20 ml
212.99
238.90
20 %
Dispersion zur Injektion/Infusion: Ferrum 1000mg / 20ml
Vifor (International)
Inc.
B / SL / SO
FB
G
SIP
IP
Ferinject 500 mg / 10 ml
5 1 Ampulle(n) à 10 ml
532.47
572.55
20 %
Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml
Vifor (International)
Inc.
B / SL / SO
FB
G
IP
CI
Requip-Modutab 2 mg
28 Tablette(n)
17.76
35.65
10 %
Tabletten mit veränderter Wirkstofffreisetzung: Ropinirolum 2 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
IP
CI
Requip-Modutab 4 mg
28 Tablette(n)
31.58
50.60
10 %
Tabletten mit veränderter Wirkstofffreisetzung: Ropinirolum 4 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
IP
CI
Requip-Modutab 8 mg
28 Tablette(n)
52.47
73.20
10 %
Tabletten mit veränderter Wirkstofffreisetzung: Ropinirolum 8 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
IP
CI
Finasterid-Mepha 5
30 Tablette(n)
15.82
33.55
10 %
Filmtabletten: Finasteridum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Finasterid-Mepha 5
100 Tablette(n)
53.56
74.65
10 %
Filmtabletten: Finasteridum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Dexamethason Galepharm 1 mg
-
T
20 Tablette(n)
4.00
13.60
10 %
Tabletten: Dexamethasonum 1 mg
Galepharm AG
B / SL / SG
FB
G
IP
CI
Dexamethason Galepharm 1 mg
-
T
100 Tablette(n)
15.80
33.60
10 %
Tabletten: Dexamethasonum 1 mg
Galepharm AG
B / SL / SG
FB
G
IP
CI
Dexamethason Galepharm 4 mg
-
T
20 Tablette(n)
10.99
28.35
10 %
Tabletten: Dexamethasonum 4 mg
Galepharm AG
B / SL / SG
FB
G
IP
CI
Dexamethason Galepharm 4 mg
-
T
100 Tablette(n)
44.24
64.55
10 %
Tabletten: Dexamethasonum 4 mg
Galepharm AG
B / SL / SG
FB
G
IP
CI
A
Matrifen 12 ug/h
5 Pflaster
k.A.
Transdermales Therapeutisches System: Fentanylum 1.38 mg
Future Health Pharma
GmbH
A+
FB
G
CI
H
Similasan Grippe und
Erkältung
15 g
k.A.
Globuli: 3 Active Agents
Similasan AG
D
FB
G
SIP
IP
Ferinject 100 mg / 2 ml
Ampulle(n) à 2 ml
k.A.
Dispersion zur Injektion/Infusion: Ferrum 100mg / 2ml
Vifor (International)
Inc.
B
FB
G
SIP
IP
Tygacil 50 mg
10
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Tigecyclinum 50 mg
Pfizer AG
A
FB
G
IP
Hexvix
Durchstechflasche(n) à 85 mg
k.A.
Future Health Pharma
GmbH
B
FB
G
Ph
Acerola Halspastillen
220 g
k.A.
Pastillen: 3 Active Agents
F. Hunziker + Co AG
E
FB
G
IP
CI
A
Matrifen 12 ug/h
10 Pflaster
k.A.
Transdermales Therapeutisches System: Fentanylum 1.38 mg
Future Health Pharma
GmbH
A+
FB
G
IP
CI
A
Matrifen 25 ug/h
5 Pflaster
k.A.
Transdermales Therapeutisches System: Fentanylum 2.75 mg
Future Health Pharma
GmbH
A+
FB
G
IP
CI
A
Matrifen 25 ug/h
10 Pflaster
k.A.
Transdermales Therapeutisches System: Fentanylum 2.75 mg
Future Health Pharma
GmbH
A+
FB
G
IP
CI
A
Matrifen 50 ug/h
5 Pflaster
k.A.
Transdermales Therapeutisches System: Fentanylum 5.5 mg
Future Health Pharma
GmbH
A+
FB
G
IP
CI
A
Matrifen 50 ug/h
10 Pflaster
k.A.
Transdermales Therapeutisches System: Fentanylum 5.5 mg
Future Health Pharma
GmbH
A+
FB
G
IP
CI
A
Matrifen 75 ug/h
5 Pflaster
k.A.
Transdermales Therapeutisches System: Fentanylum 8.25 mg
Future Health Pharma
GmbH
A+
FB
G
IP
CI
A
Matrifen 75 ug/h
10 Pflaster
k.A.
Transdermales Therapeutisches System: Fentanylum 8.25 mg
Future Health Pharma
GmbH
A+
FB
G
IP
CI
A
Matrifen 100 ug/h
5 Pflaster
k.A.
Transdermales Therapeutisches System: Fentanylum 11 mg
Future Health Pharma
GmbH
A+
FB
G
IP
CI
A
Matrifen 100 ug/h
10 Pflaster
k.A.
Transdermales Therapeutisches System: Fentanylum 11 mg
Future Health Pharma
GmbH
A+
FB
G
CI
H
Similasan Grippe und
Erkältung
4.5 g
k.A.
Globuli: 3 Active Agents
Similasan AG
D
FB
G
IP
Fluconazol Redibag Baxter 200 mg
10 1 Poche(s) perfusion(s) à 100 ml
k.A.
Infusionslösung: Fluconazolum 200mg / 100ml
Baxter AG
B
FB
G
IP
Finasterid Streuli 5
28 Tablette(n)
15.05
33.70
k.A.
Filmtabletten: Finasteridum 5 mg
Streuli Pharma AG
B
FB
G
IP
Finasterid Streuli 5
98 Tablette(n)
52.49
76.65
k.A.
Filmtabletten: Finasteridum 5 mg
Streuli Pharma AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
